Toll-like receptor 4 deficiency or inhibition does not modulate survival and neurofunctional outcome in a murine model of cardiac arrest and resuscitation.
Stefan BergtAndrea GrubMelanie MuellerRika BajoratIvan BarilarBrigitte VollmarJan Patrick RoesnerNana-Maria WagnerPublished in: PloS one (2019)
Therapeutic strategies targeting TLR4 may not be suitable for the reduction of mortality or neurofunctional impairment after CA/CPR.